CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 116 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $10,784,000 | -60.4% | 400,000 | -50.0% | 0.02% | -51.9% |
| Q1 2022 | $27,248,000 | +8.5% | 800,000 | +23.1% | 0.05% | +15.6% |
| Q4 2021 | $25,116,000 | -51.0% | 650,000 | -31.6% | 0.04% | -55.4% |
| Q3 2021 | $51,291,000 | -15.7% | 950,000 | -47.8% | 0.10% | -15.1% |
| Q2 2021 | $60,810,000 | +55.4% | 1,818,478 | -4.3% | 0.12% | +48.8% |
| Q1 2021 | $39,140,000 | -10.6% | 1,900,000 | -24.0% | 0.08% | -15.8% |
| Q4 2020 | $43,800,000 | +44.1% | 2,500,000 | +22.0% | 0.10% | +25.0% |
| Q3 2020 | $30,402,000 | +33.6% | 2,050,000 | +17.1% | 0.08% | +31.0% |
| Q2 2020 | $22,750,000 | – | 1,750,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |